CN1057072A - 单克隆抗IgM抗体，它们的生产和用途，以及产生同样物质的杂交瘤 - Google Patents

单克隆抗IgM抗体，它们的生产和用途，以及产生同样物质的杂交瘤 Download PDF

Info

Publication number
CN1057072A
CN1057072A CN91102913A CN91102913A CN1057072A CN 1057072 A CN1057072 A CN 1057072A CN 91102913 A CN91102913 A CN 91102913A CN 91102913 A CN91102913 A CN 91102913A CN 1057072 A CN1057072 A CN 1057072A
Authority
CN
China
Prior art keywords
antibody
igm
hybridoma
cell
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN91102913A
Other languages
English (en)
Chinese (zh)
Inventor
米切尔·G·罗森布勒姆
尼克拉斯·J·多纳托
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESEARCH DEVELOPMENT FOUDATION
Research Development Foundation
Original Assignee
RESEARCH DEVELOPMENT FOUDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RESEARCH DEVELOPMENT FOUDATION filed Critical RESEARCH DEVELOPMENT FOUDATION
Publication of CN1057072A publication Critical patent/CN1057072A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN91102913A 1990-04-27 1991-04-27 单克隆抗IgM抗体，它们的生产和用途，以及产生同样物质的杂交瘤 Pending CN1057072A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51597490A 1990-04-27 1990-04-27
US515,974 1990-04-27

Publications (1)

Publication Number Publication Date
CN1057072A true CN1057072A (zh) 1991-12-18

Family

ID=24053580

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91102913A Pending CN1057072A (zh) 1990-04-27 1991-04-27 单克隆抗IgM抗体，它们的生产和用途，以及产生同样物质的杂交瘤

Country Status (12)

Country Link
EP (1) EP0538267A4 (pt)
JP (1) JPH06504424A (pt)
CN (1) CN1057072A (pt)
CA (1) CA2079901A1 (pt)
IE (1) IE911172A1 (pt)
IL (1) IL97827A0 (pt)
NZ (1) NZ237784A (pt)
PT (1) PT97482B (pt)
RU (1) RU2105062C1 (pt)
TW (1) TW349995B (pt)
WO (1) WO1991017257A1 (pt)
ZA (1) ZA912695B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108384761B (zh) * 2018-03-30 2020-08-11 四川迈克生物新材料技术有限公司 抗人IgM单克隆抗体、其杂交瘤细胞株及应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2734704C (en) 2008-09-05 2017-06-20 Sekisui Medical Co., Ltd. Anti-human igm monoclonal antibody and immunoassay using the same
CN116143931B (zh) * 2021-11-20 2023-10-31 东莞市朋志生物科技有限公司 一种抗人IgM抗体及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792447A (en) * 1981-07-23 1988-12-20 Board Of Regents, The University Of Texas System Anti-immunoglobulin toxin conjugates useful in the treatment of B cell tumors
AU9016591A (en) * 1990-10-25 1992-05-26 Tanox Biosystems, Inc. Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on B cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108384761B (zh) * 2018-03-30 2020-08-11 四川迈克生物新材料技术有限公司 抗人IgM单克隆抗体、其杂交瘤细胞株及应用

Also Published As

Publication number Publication date
RU2105062C1 (ru) 1998-02-20
ZA912695B (en) 1993-02-24
CA2079901A1 (en) 1991-10-28
EP0538267A4 (en) 1994-06-01
JPH06504424A (ja) 1994-05-26
PT97482B (pt) 1998-08-31
IE911172A1 (en) 1991-11-06
EP0538267A1 (en) 1993-04-28
NZ237784A (en) 1992-09-25
IL97827A0 (en) 1992-06-21
WO1991017257A1 (en) 1991-11-14
AU650659B2 (en) 1994-06-30
AU7866491A (en) 1991-11-27
PT97482A (pt) 1992-01-31
TW349995B (en) 1999-01-11

Similar Documents

Publication Publication Date Title
US4536479A (en) Use of anti-idiotype antibodies in immunoassays
Goding Use of staphylococcal protein A as an immunological reagent
Fambrough et al. Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies.
JP2540179B2 (ja) 非還元・非酵素的糖鎖形成蛋白に対するモノクロ―ナル抗体
CN1907953A (zh) 一种用于氯胺酮检测的单克隆抗体及免疫检测板
JPS6357599A (ja) イヌ心糸状虫ワクチンおよび診断試験
Theofilopoulos et al. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
CN110607283A (zh) 一株分泌三氯杀螨醇单克隆抗体的杂交瘤细胞株cbc及其应用
CN101062949A (zh) 重组抗人IgE单克隆抗体及其制备方法和用途
Kessler et al. Surface membrane kappa and lambda light chain expression on spleen cells of neonatal and maturing normal and immune-defective CBA/NB mice: the kappa: lambda ratio is constant.
CN1057072A (zh) 单克隆抗IgM抗体，它们的生产和用途，以及产生同样物质的杂交瘤
JPH03198795A (ja) 種々のヒト白血病およびリンパ腫細胞上に広く存在する特有の抗原に反応するモノクローナル抗体、および診断および治療を目的とした該抗体の使用法
CN1867584A (zh) 天然免疫球蛋白结合试剂及其制造和使用方法
US6306626B1 (en) Anti-IgM monoclonal antibodies and methods of their use
Hopkins et al. Monoclonal antibodies to the sheep analogues of human CD45 (leucocyte common antigen), MHC class I and CD5. Differential expression after lymphocyte activation in vivo
CN1833168A (zh) 用于检测饲料酶的试剂、方法和试剂盒
EP0575906A2 (en) Sandwich immunoassay of beta-N-acetylglucosaminidase and monoclonal antibody used therein
KR970009892B1 (ko) 모노클로날 향체 및 피토프토라 감염 진단법
JPH0672892B2 (ja) ヒト血中のヒトプロリルヒドロキシラーゼの酵素免疫定量法
US4746612A (en) Aotus interspecies hybridomas and monoclonal receptors produced thereby
CN1502630A (zh) 一种o6－甲基鸟嘌呤－dna甲基转移酶的单克隆抗体，其制备方法及检测试剂盒
CN1189484C (zh) 重组抗人CD11a单克隆抗体及其制法和药物组合物
JP2004091454A (ja) 抗体及びその製造方法並びに抗体を用いた抗原の定量方法
AU650659C (en) Monoclonal anti-IgM antibodies, their production and use, and hybridomas for producing the same
Evans et al. A function-associated molecule on rat natural killer cells identified by anti-idiotypic monoclonal antibodies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)